Pfizer Inc
PFE· NYSE
Released May 2, 2023, before the open
10-Q filed May 10, 2023, 38 days after period end · 0001628280-23-017196
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $18.49B | $25.66B | $14.52B | $10.08B |
| Net Income | $5.54B | $7.86B | $4.88B | $3.36B |
| EPS Diluted |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.97 |
| $1.37 |
| $0.86 |
| $0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.